Search Results
Onco
Daily
Facebook
RSS
X
Youtube
Linkedin
October, 2024
October 2024
M
T
W
T
F
S
S
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
« Sep
FDA
May 30, 2024, 16:14 |
Blog
Alexander González: The challenges of CARNK existing in the process from lab production to tumor infiltration
Alexander González, Internal Clinician at 3cert Limited, shared on LinkedIn: “The challenges of CARNK existing…
May 30, 2024, 12:55 |
Immune Oncology
History of Immunotherapy: Cancer Treatment
Immunotherapy Immunotherapy is a revolutionary approach to cancer treatment that harnesses the power of the…
May 29, 2024, 22:44 |
Blog
Vivek Subbiah: Prepping to ASCO24 - Super Bowl for oncology
Vivek Subbiah shared on LinkedIn: "Countdown to ASCO24 Annual meeting is on! Excited for the biggest cancer…
May 29, 2024, 13:58 |
Insight
Daniel Michaeli: Our new article ‘Clinical trial design and treatment effects’
Daniel Michaeli, Medical Doctor at National Center for Tumor Diseases (NCT) Heidelberg, shared a post on…
May 29, 2024, 02:50 |
Positive
Vivek Subbiah Receives 2024 Yvonne Award in the Voice of Oncology Category
Yvonne Award Winners 2024 by OncoDaily We are excited to announce the esteemed winners of…
May 27, 2024, 07:31 |
Blog
Uromigos: Team Canada Have Entered the Uromigos Cup
Petros Grivas shared a post by Uromigos on X: “Welcoming wonderful teams with amazing colleagues/friends to…
May 26, 2024, 15:35 |
Insight
Sumanta Pal: A massive effort to characterize the activity of Debio1347 by Petros Grivas and colleagues
Petros Grivas shared a post by Sumanta Pal on X/Twitter: "Thanks Sumanta Pal for highlighting our work with…
May 26, 2024, 14:20 |
Blog
C. Ola Landgren on Quadruple Therapies and the Future of Multiple Myeloma Treatment
Sylvester researcher C. Ola Landgren will present an overview of new studies and the state…
May 26, 2024, 06:31 |
Insight
Vivek Subbiah: Impressive response to dabrafenib, trametinib, and osimertinib in a metastatic EGFR-mutant/BRAF V600E lung adenocarcinoma
Vivek Subbiah shared a post on X/Twitter: "Impressive response to dabrafenib, trametinib, and osimertinib in a…
May 25, 2024, 12:41 |
Insight
Vivek Subbiah: KRAS inhibitors are here to stay
Vivek Subbiah shared on X: “KRAS inhibitors are here ASCO24 & here to stay for all…
57
58
59
60
61
All:
950
Posts:
581 - 590
100 Influential Women in Oncology: Key Opinion Leaders to Follow on Social Media in 2024: Part 6
ASTRO24: 15 Posts Not To Miss From Day 4
Top 100 Xfluencers in Prostate Cancer: Key Opinion Leaders to follow on X (Twitter) in 2024
Paper Alert! Cutaneous Metastases in Thyroid Cancer: A Comprehensive Review of 136 Cases
ASTRO 24: 15 Posts Not to Miss From Day 3
Special Coverage
ASCO Annual Meeting
May 30 - June 4, 2024
Yvonne Award 2024
May 31, 2024
OncoThon 2024, Online
Feb. 15, 2024
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Facebook
RSS Feed
X
Linkedin
Youtube